BIOFORE
Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 croreViyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion...
Optimistic of delivering better growth than last year: CT Renganathan, MD, RPG LifescienceCT Renganathan, MD, RPG Lifescience said that our international business has kicked up very well. We have grown by 174%. Our domestic busin...
- Load More